カテゴリー： QYResearch, 世界

世界のポンペ病治療薬市場 2019年

【英語タイトル】Global Pompe Disease Drugs Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X13429）・商品コード：DATA909X13429
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、ポンペ病治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、肝臓薬、心臓薬、筋肉薬に、用途別には、病院、診療所、その他にセグメント区分し、ポンペ病治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・ポンペ病治療薬の世界市場概要
・ポンペ病治療薬の製造コスト構成分析
・ポンペ病治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・ポンペ病治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・ポンペ病治療薬のセグメント分析（種類別）
（肝臓薬、心臓薬、筋肉薬）
・ポンペ病治療薬のセグメント分析（用途別）
（病院、診療所、その他）
・ポンペ病治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Genzyme（A Sanofi Company)、BioMarin、Amicus、Audentes、EpiVax、Oxyrane、Sangamo、Valerion Therapeutics、）
・ポンペ病治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Pompe Disease Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Pompe Disease Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pompe Disease Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pompe Disease Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pompe Disease Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Genzyme（A Sanofi Company)
BioMarin
Amicus
Audentes
EpiVax
Oxyrane
Sangamo
Valerion Therapeutics

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Liver Drugs
Heart Drugs
Muscle Drugs

Segment by Application
Hospital
Clinic
Other

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Pompe Disease Drugs
1.1 Definition of Pompe Disease Drugs
1.2 Pompe Disease Drugs Segment by Type
1.2.1 Global Pompe Disease Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Liver Drugs
1.2.3 Heart Drugs
1.2.4 Muscle Drugs
1.3 Pompe Disease Drugs Segment by Applications
1.3.1 Global Pompe Disease Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Pompe Disease Drugs Overall Market
1.4.1 Global Pompe Disease Drugs Revenue (2014-2025)
1.4.2 Global Pompe Disease Drugs Production (2014-2025)
1.4.3 North America Pompe Disease Drugs Status and Prospect (2014-2025)
1.4.4 Europe Pompe Disease Drugs Status and Prospect (2014-2025)
1.4.5 China Pompe Disease Drugs Status and Prospect (2014-2025)
1.4.6 Japan Pompe Disease Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Pompe Disease Drugs Status and Prospect (2014-2025)
1.4.8 India Pompe Disease Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Pompe Disease Drugs
2.3 Manufacturing Process Analysis of Pompe Disease Drugs
2.4 Industry Chain Structure of Pompe Disease Drugs

3 Development and Manufacturing Plants Analysis of Pompe Disease Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Pompe Disease Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Pompe Disease Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Pompe Disease Drugs Production and Capacity Analysis
4.2 Pompe Disease Drugs Revenue Analysis
4.3 Pompe Disease Drugs Price Analysis
4.4 Market Concentration Degree

5 Pompe Disease Drugs Regional Market Analysis
5.1 Pompe Disease Drugs Production by Regions
5.1.1 Global Pompe Disease Drugs Production by Regions
5.1.2 Global Pompe Disease Drugs Revenue by Regions
5.2 Pompe Disease Drugs Consumption by Regions
5.3 North America Pompe Disease Drugs Market Analysis
5.3.1 North America Pompe Disease Drugs Production
5.3.2 North America Pompe Disease Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Pompe Disease Drugs Import and Export
5.4 Europe Pompe Disease Drugs Market Analysis
5.4.1 Europe Pompe Disease Drugs Production
5.4.2 Europe Pompe Disease Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Pompe Disease Drugs Import and Export
5.5 China Pompe Disease Drugs Market Analysis
5.5.1 China Pompe Disease Drugs Production
5.5.2 China Pompe Disease Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Pompe Disease Drugs Import and Export
5.6 Japan Pompe Disease Drugs Market Analysis
5.6.1 Japan Pompe Disease Drugs Production
5.6.2 Japan Pompe Disease Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Pompe Disease Drugs Import and Export
5.7 Southeast Asia Pompe Disease Drugs Market Analysis
5.7.1 Southeast Asia Pompe Disease Drugs Production
5.7.2 Southeast Asia Pompe Disease Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Pompe Disease Drugs Import and Export
5.8 India Pompe Disease Drugs Market Analysis
5.8.1 India Pompe Disease Drugs Production
5.8.2 India Pompe Disease Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Pompe Disease Drugs Import and Export

6 Pompe Disease Drugs Segment Market Analysis (by Type)
6.1 Global Pompe Disease Drugs Production by Type
6.2 Global Pompe Disease Drugs Revenue by Type
6.3 Pompe Disease Drugs Price by Type

7 Pompe Disease Drugs Segment Market Analysis (by Application)
7.1 Global Pompe Disease Drugs Consumption by Application
7.2 Global Pompe Disease Drugs Consumption Market Share by Application (2014-2019)

8 Pompe Disease Drugs Major Manufacturers Analysis
8.1 Genzyme（A Sanofi Company)
8.1.1 Genzyme（A Sanofi Company) Pompe Disease Drugs Production Sites and Area Served
8.1.2 Genzyme（A Sanofi Company) Product Introduction, Application and Specification
8.1.3 Genzyme（A Sanofi Company) Pompe Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 BioMarin
8.2.1 BioMarin Pompe Disease Drugs Production Sites and Area Served
8.2.2 BioMarin Product Introduction, Application and Specification
8.2.3 BioMarin Pompe Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Amicus
8.3.1 Amicus Pompe Disease Drugs Production Sites and Area Served
8.3.2 Amicus Product Introduction, Application and Specification
8.3.3 Amicus Pompe Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Audentes
8.4.1 Audentes Pompe Disease Drugs Production Sites and Area Served
8.4.2 Audentes Product Introduction, Application and Specification
8.4.3 Audentes Pompe Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 EpiVax
8.5.1 EpiVax Pompe Disease Drugs Production Sites and Area Served
8.5.2 EpiVax Product Introduction, Application and Specification
8.5.3 EpiVax Pompe Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Oxyrane
8.6.1 Oxyrane Pompe Disease Drugs Production Sites and Area Served
8.6.2 Oxyrane Product Introduction, Application and Specification
8.6.3 Oxyrane Pompe Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Sangamo
8.7.1 Sangamo Pompe Disease Drugs Production Sites and Area Served
8.7.2 Sangamo Product Introduction, Application and Specification
8.7.3 Sangamo Pompe Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Valerion Therapeutics
8.8.1 Valerion Therapeutics Pompe Disease Drugs Production Sites and Area Served
8.8.2 Valerion Therapeutics Product Introduction, Application and Specification
8.8.3 Valerion Therapeutics Pompe Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Pompe Disease Drugs Market
9.1 Global Pompe Disease Drugs Market Trend Analysis
9.1.1 Global Pompe Disease Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Pompe Disease Drugs Regional Market Trend
9.2.1 North America Pompe Disease Drugs Forecast 2019-2025
9.2.2 Europe Pompe Disease Drugs Forecast 2019-2025
9.2.3 China Pompe Disease Drugs Forecast 2019-2025
9.2.4 Japan Pompe Disease Drugs Forecast 2019-2025
9.2.5 Southeast Asia Pompe Disease Drugs Forecast 2019-2025
9.2.6 India Pompe Disease Drugs Forecast 2019-2025
9.3 Pompe Disease Drugs Market Trend (Product Type)
9.4 Pompe Disease Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Pompe Disease Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Pompe Disease Drugs
Table Global Pompe Disease Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Pompe Disease Drugs Production Market Share by Types in 2018
Figure Liver Drugs Product Picture
Figure Heart Drugs Product Picture
Figure Muscle Drugs Product Picture
Table Global Pompe Disease Drugs Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Pompe Disease Drugs Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Other
Figure Global Pompe Disease Drugs Revenue (Million USD) (2014-2025)
Figure Global Pompe Disease Drugs Production (K Pcs) (2014-2025)
Figure North America Pompe Disease Drugs Market Size (Million USD) (2014-2025)
Figure Europe Pompe Disease Drugs Market Size (Million USD) (2014-2025)
Figure China Pompe Disease Drugs Market Size (Million USD) (2014-2025)
Figure Japan Pompe Disease Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Pompe Disease Drugs Market Size (Million USD) (2014-2025)
Figure India Pompe Disease Drugs Market Size (Million USD) (2014-2025)
Table Pompe Disease Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Pompe Disease Drugs in 2018
Figure Manufacturing Process Analysis of Pompe Disease Drugs
Figure Industry Chain Structure of Pompe Disease Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Pompe Disease Drugs Manufacturing Plants Distribution
Table Pompe Disease Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Pompe Disease Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Pompe Disease Drugs Production (K Pcs) of Major Manufacturers (2014-2019)
Table Pompe Disease Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Pompe Disease Drugs Production Share by Manufacturers in 2018
Table Pompe Disease Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Pompe Disease Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Pompe Disease Drugs Revenue Share by Manufacturers in 2018
Table Pompe Disease Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Pompe Disease Drugs Production by Regions 2014-2019 (K Pcs)
Table Global Pompe Disease Drugs Production Market Share by Regions 2014-2019
Figure Global Pompe Disease Drugs Production Market Share by Regions in 2018
Table Global Pompe Disease Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Pompe Disease Drugs Revenue Market Share by Regions 2014-2019
Figure Global Pompe Disease Drugs Revenue Market Share by Regions in 2018
Table Global Pompe Disease Drugs Consumption by Regions 2014-2019 (K Pcs)
Table Global Pompe Disease Drugs Consumption Market Share by Regions 2014-2019
Figure North America Pompe Disease Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure North America Pompe Disease Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Pompe Disease Drugs Production, Consumption Import and Export (K Pcs)
Figure Europe Pompe Disease Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Pompe Disease Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Pompe Disease Drugs Production, Consumption Import and Export (K Pcs)
Figure China Pompe Disease Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure China Pompe Disease Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Pompe Disease Drugs Production, Consumption Import and Export (K Pcs)
Figure Japan Pompe Disease Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Pompe Disease Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Pompe Disease Drugs Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Pompe Disease Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Pompe Disease Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Pompe Disease Drugs Production, Consumption Import and Export (K Pcs)
Figure India Pompe Disease Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure India Pompe Disease Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Pompe Disease Drugs Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Pompe Disease Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Pompe Disease Drugs Market Share by Application (2014-2019)
Table Genzyme（A Sanofi Company) Pompe Disease Drugs Production Sites and Area Served
Table Genzyme（A Sanofi Company) Pompe Disease Drugs Product Introduction, Application and Specification
Table Genzyme（A Sanofi Company) Pompe Disease Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Genzyme（A Sanofi Company) Pompe Disease Drugs Production Growth Rate (2014-2019)
Table Genzyme（A Sanofi Company) Pompe Disease Drugs Production Market Share (2014-2019)
Figure Genzyme（A Sanofi Company) Pompe Disease Drugs Revenue Market Share (2014-2019)
Table Genzyme（A Sanofi Company) Pompe Disease Drugs Main Business and Markets Served
Table BioMarin Pompe Disease Drugs Production Sites and Area Served
Table BioMarin Pompe Disease Drugs Product Introduction, Application and Specification
Table BioMarin Pompe Disease Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BioMarin Pompe Disease Drugs Production Growth Rate (2014-2019)
Table BioMarin Pompe Disease Drugs Production Market Share (2014-2019)
Figure BioMarin Pompe Disease Drugs Revenue Market Share (2014-2019)
Table BioMarin Pompe Disease Drugs Main Business and Markets Served
Table Amicus Pompe Disease Drugs Production Sites and Area Served
Table Amicus Pompe Disease Drugs Product Introduction, Application and Specification
Table Amicus Pompe Disease Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amicus Pompe Disease Drugs Production Growth Rate (2014-2019)
Table Amicus Pompe Disease Drugs Production Market Share (2014-2019)
Figure Amicus Pompe Disease Drugs Revenue Market Share (2014-2019)
Table Amicus Pompe Disease Drugs Main Business and Markets Served
Table Audentes Pompe Disease Drugs Production Sites and Area Served
Table Audentes Pompe Disease Drugs Product Introduction, Application and Specification
Table Audentes Pompe Disease Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Audentes Pompe Disease Drugs Production Growth Rate (2014-2019)
Table Audentes Pompe Disease Drugs Production Market Share (2014-2019)
Figure Audentes Pompe Disease Drugs Revenue Market Share (2014-2019)
Table Audentes Pompe Disease Drugs Main Business and Markets Served
Table EpiVax Pompe Disease Drugs Production Sites and Area Served
Table EpiVax Pompe Disease Drugs Product Introduction, Application and Specification
Table EpiVax Pompe Disease Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table EpiVax Pompe Disease Drugs Production Growth Rate (2014-2019)
Table EpiVax Pompe Disease Drugs Production Market Share (2014-2019)
Figure EpiVax Pompe Disease Drugs Revenue Market Share (2014-2019)
Table EpiVax Pompe Disease Drugs Main Business and Markets Served
Table Oxyrane Pompe Disease Drugs Production Sites and Area Served
Table Oxyrane Pompe Disease Drugs Product Introduction, Application and Specification
Table Oxyrane Pompe Disease Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Oxyrane Pompe Disease Drugs Production Growth Rate (2014-2019)
Table Oxyrane Pompe Disease Drugs Production Market Share (2014-2019)
Figure Oxyrane Pompe Disease Drugs Revenue Market Share (2014-2019)
Table Oxyrane Pompe Disease Drugs Main Business and Markets Served
Table Sangamo Pompe Disease Drugs Production Sites and Area Served
Table Sangamo Pompe Disease Drugs Product Introduction, Application and Specification
Table Sangamo Pompe Disease Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sangamo Pompe Disease Drugs Production Growth Rate (2014-2019)
Table Sangamo Pompe Disease Drugs Production Market Share (2014-2019)
Figure Sangamo Pompe Disease Drugs Revenue Market Share (2014-2019)
Table Sangamo Pompe Disease Drugs Main Business and Markets Served
Table Valerion Therapeutics Pompe Disease Drugs Production Sites and Area Served
Table Valerion Therapeutics Pompe Disease Drugs Product Introduction, Application and Specification
Table Valerion Therapeutics Pompe Disease Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Valerion Therapeutics Pompe Disease Drugs Production Growth Rate (2014-2019)
Table Valerion Therapeutics Pompe Disease Drugs Production Market Share (2014-2019)
Figure Valerion Therapeutics Pompe Disease Drugs Revenue Market Share (2014-2019)
Table Valerion Therapeutics Pompe Disease Drugs Main Business and Markets Served
Figure Global Pompe Disease Drugs Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Pompe Disease Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Pompe Disease Drugs Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Pompe Disease Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Pompe Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Pompe Disease Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Pompe Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Pompe Disease Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Pompe Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Pompe Disease Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Pompe Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Pompe Disease Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Pompe Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Pompe Disease Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Pompe Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Pompe Disease Drugs by Type (2019-2025)
Table Global Consumption (K Pcs) of Pompe Disease Drugs by Application (2019-2025)
Table Pompe Disease Drugs Distributors List
Table Pompe Disease Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Genzyme（A Sanofi Company)、BioMarin、Amicus、Audentes、EpiVax、Oxyrane、Sangamo、Valerion Therapeutics、

★調査レポート[世界のポンペ病治療薬市場 2019年] (コード：DATA909X13429)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のポンペ病治療薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の末期腎不全（ESRD）薬市場 2019年
    DATA909X07327 / QYResearch / 2019年11月15日 / ※本調査レポートは、末期腎不全（ESRD）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、コハク酸カルシウム、Mk-3866、パクリチニブ、サンギネート、テシドールマブ、その他に、用途別には、病院、診療所、ICU、その他にセグメント区分し、末期腎不全（ESRD）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・末期腎不全（ESRD）薬の世界市場概要 ・末期腎不全（ESRD）薬の製造コスト構成分析 ・末期腎不全（ESRD）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・末期腎不全（ESRD）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・末期腎不全（ESRD）薬のセグメント分析（種類別） （コハク酸カルシウム、Mk-3866、パクリチニブ、サンギネート、テシドールマブ、その他）...The global End-Stage Renal Disease (ESRD) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on End-Stage Renal Disease (ESRD) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall End-Stage Renal Disease (ESRD) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of End-Stage Renal Disease (ESRD) Drugs in North America, Europe, China, Japan, Southeast Asia and...
  • アルツハイマー病治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102940 / GlobalInfoResearch / 2019年9月24日 / 本調査レポートは、アルツハイマー病治療薬の世界市場について調べ、まとめました。種類別セグメントは、コリンエステラーゼ阻害剤、NMDAアンタゴニスト等、用途別セグメントは、ドラッグストア、小売店、その他等に区分しました。アルツハイマー病治療薬の世界市場概観、メーカー動向、メーカー別アルツハイマー病治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アルツハイマー病治療薬の市場概観 ・アルツハイマー病治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アルツハイマー病治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・アルツハイマー病治療薬の世界市場規模 ・アルツハイマー病治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・アルツハイマー病治療薬のアメリカ市場規模推移 ・アルツハイマー病治療薬のカナダ市場規模推移 ・アルツハイマー病治療薬のメキシコ市場規模推移 ・アルツハイマー病治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Alzheimer's is a chronic neurodegenerative disease that usually starts slowly and worsens over time. Scope of the Report: The worldwide market for Alzheimer's Disease Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Alzheimer's Disease Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment...
  • 世界の血液脳関門輸送薬市場 2019年
    DATA909X04677 / QYResearch / 2019年11月15日 / ※本調査レポートは、血液脳関門輸送薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、キャリア媒介輸送、受容体媒介輸送、吸収媒介輸送、能動排出輸送、その他に、用途別には、アルツハイマー病、てんかん、パーキンソン病、多発性硬化症、ハンター症候群、脳がん、その他にセグメント区分し、血液脳関門輸送薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・血液脳関門輸送薬の世界市場概要 ・血液脳関門輸送薬の製造コスト構成分析 ・血液脳関門輸送薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・血液脳関門輸送薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・血液脳関門輸送薬のセグメント分析（種類別） （キャリア媒介輸送、受容体媒介輸送、吸収媒介輸送、能動排出輸送、その他）...The global Blood-Brain Barrier Transport Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Blood-Brain Barrier Transport Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood-Brain Barrier Transport Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Blood-Brain Barrier Transport Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の異常ヘモグロビン症薬市場 2019年
    DATA909X08940 / QYResearch / 2019年11月20日 / ※本調査レポートは、異常ヘモグロビン症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、サラセミア療法、鎌状赤血球症（SCD）療法、その他療法に、用途別には、アルファサラセミア、ベータサラセミア、鎌状赤血球症、Hbバリアント病にセグメント区分し、異常ヘモグロビン症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・異常ヘモグロビン症薬の世界市場概要 ・異常ヘモグロビン症薬の製造コスト構成分析 ・異常ヘモグロビン症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・異常ヘモグロビン症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・異常ヘモグロビン症薬のセグメント分析（種類別） （サラセミア療法、鎌状赤血球症（SCD）療法、その他療法）...The global Hemoglobinopathies Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hemoglobinopathies Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hemoglobinopathies Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hemoglobinopathies Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hemoglobinopathies Drugs manufacturing...

    • ◆H&Iグローバルリサーチのお客様（例）◆